ELIZABETH MARTINEZ: Open Payments
NPI 1912652637 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 10 payments from 7 companies in 2025. Trend: 2023 $983 · 2024 $1,038 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $223 |
| Lilly USA, LLC | 2 | $135 |
| Corcept Therapeutics | 1 | $127 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
Products named: MOUNJARO, Korlym, REXULTI, GATTEX, XIFAXAN, OFEV.
Industry payments across TX — which companies pay providers there.
